Theseus Pharmaceuticals

OverviewSuggest Edit

Theseus Pharmaceuticals is a biotechnology company focused on oncology. The company specializes in the research and development of therapies designed to anticipate and inhibit treatment-resistant cancer mutations. The drug lead candidate the company develops, THE-630, is a pan-variant KIT inhibitor in development for the treatment of refractory GIST. It also develops a selective EGFR inhibitor to overcome C797S-mediated resistance to first- or later-line osimertinib treatment for patients with non-small cell lung cancer.
TypePublic
Founded2017
HQCambridge, MA, US
Websitetheseusrx.com

Latest Updates

Employees (est.) (Sept 2021)14
Share Price (Oct 2021)$16
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Theseus Pharmaceuticals

Timothy P. Clackson

Timothy P. Clackson

President & Chief Executive Officer
Victor Rivera

Victor Rivera

Co-Founder, Chief Scientific Officer
David Dalgarno

David Dalgarno

Co-Founder, Chief Technical Officer
Katie Dahlstrom

Katie Dahlstrom

Vice President, Clinical Operations
Wei-Sheng Huang

Wei-Sheng Huang

Co-Founder, Vice President, Chemistry
Nachu Narasimhan

Nachu Narasimhan

Senior Vice President, Drug Metabolism & Preclinical Safety
Show more

Theseus Pharmaceuticals Office Locations

Theseus Pharmaceuticals has an office in Cambridge
Cambridge, MA, US (HQ)
245 Main St
Show all (1)

Theseus Pharmaceuticals Financials and Metrics

Theseus Pharmaceuticals Revenue

Market capitalization (13-Oct-2021)

585.1m

Closing stock price (13-Oct-2021)

15.6
Theseus Pharmaceuticals's current market capitalization is $585.1 m.
Show all financial metrics

Theseus Pharmaceuticals Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Theseus Pharmaceuticals Online and Social Media Presence

Embed Graph

Theseus Pharmaceuticals News and Updates

Theseus Pharmaceuticals Raises $100M in Series B Funding

Theseus Pharmaceuticals, a Boston, MA-based biotechnology company focused on oncology by developing pan-variant kinase inhibitors, emerged from stealth with the close of a $100m Series B financing

Theseus Pharmaceuticals Frequently Asked Questions

  • When was Theseus Pharmaceuticals founded?

    Theseus Pharmaceuticals was founded in 2017.

  • Who are Theseus Pharmaceuticals key executives?

    Theseus Pharmaceuticals's key executives are Timothy P. Clackson, Victor Rivera and David Dalgarno.

  • How many employees does Theseus Pharmaceuticals have?

    Theseus Pharmaceuticals has 14 employees.

  • Who are Theseus Pharmaceuticals competitors?

    Competitors of Theseus Pharmaceuticals include Nimbus Therapeutics, AstraZeneca and Angimmune.

  • Where is Theseus Pharmaceuticals headquarters?

    Theseus Pharmaceuticals headquarters is located at 245 Main St, Cambridge.

  • Where are Theseus Pharmaceuticals offices?

    Theseus Pharmaceuticals has an office in Cambridge.

  • How many offices does Theseus Pharmaceuticals have?

    Theseus Pharmaceuticals has 1 office.